Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The US China Innovation Alliance (USCIA) is a non-profit organization that facilitates cross-border collaboration, investment, and technology transfer between the United States and China, with a primary focus on the life sciences and healthcare industries. Headquartered in Houston, Texas, the alliance is best known for organizing the US-China Innovation and Investment Summit (UCIS) and the InnoSTARS competition, which provide a platform for U.S.-based startups to connect with Chinese investors and strategic partners. USCIA offers a range of services including market entry consulting, matchmaking, and networking events designed to help innovative companies navigate the complexities of the Chinese market. By bridging the gap between these two major economies, the organization aims to accelerate the commercialization of advanced medical technologies and digital health solutions. The alliance works closely with academic institutions, government agencies, and industry leaders to foster a robust ecosystem for international innovation. Through its initiatives, USCIA has supported hundreds of early-stage companies in securing funding and establishing strategic partnerships across the Pacific.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on US China Innovation Alliance.